Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
4.31 (1y: +78%)
Market Cap 67.8 M P/E(ttm)
Enterprise Value 39.95 M P/B
BIOD- NAS (USA)
Biodel, Inc.
Not Rated
Top Ranked Predictable Companies
$4.31
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M67.8Revenue $M0Net Margin (%)0Z-Score0
Enterprise Value $M40.0EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with BIOD

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.

No Entry found!
Total Records: 0

BIOD is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Premium Most recent portfolio changes are included for Premium Members only!


BIOD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-12-07Sell12,256$2.854.64view
Krasner Alan SethChief Medical Officer 2012-11-02Sell3,500$2.8154.09view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-11-02Sell3,500$2.8154.09view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-03-13Sell2,096$2.3683.47view
Pereira Brian JGDirector 2011-12-16Sell3,750$2.666.54view
Steiner SolomonDirector 2011-09-26Sell32,695$4.36-0.69view
Steiner SolomonDirector 2011-09-21Sell79,129$4.72-8.26view
Krasner Alan SethChief Medical Officer 2011-09-20Sell964$4.68-7.48view
URCIUOLI J ARTHURDirector 2011-09-20Buy2,500$4.72-8.26view
Steiner SolomonDirector 2011-09-16Sell56,644$4.88-11.27view

Press Releases about BIOD :

Quarterly/Annual Reports about BIOD:

News about BIOD:

Articles On GuruFocus.com
cooldecency99 note on BIOD May 01 2010 
Biodel Reports Third Quarter Fiscal Year 2009 Financial Results Aug 07 2009 
Biodel to Report Third Quarter Fiscal Year 2009 Results on August 7, 2009 Aug 03 2009 
Biodel Reports First Quarter Fiscal Year 2009 Financial Results and Clinical Update Feb 05 2009 
Biodel to Report First Quarter Fiscal Year 2009 Results and Top Line Results of Bioequivalence Study Jan 30 2009 
Biodel Inc. Reports Fourth Quarter and Fiscal Year 2008 Financial Results Dec 10 2008 

More From Our Partners
Afternoon Market Losers Jun 19 2013 - BENZINGA

Add Notes, Comments or Ask Questions

Please log in first

Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK